RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00508807
Recruitment Status : Completed
First Posted : July 30, 2007
Last Update Posted : July 30, 2012
Reata Pharmaceuticals, Inc.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2009
  Study Completion Date : December 2009